Invesco’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Invesco’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,960	Closed	-$298K	–	4123
2021 Q1	$298K	Buy	+4,960	New	+$180K	﹤0.01%	3554

Invesco's PAND Position: Q2 2021 in Review

Invesco sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 4,960 shares — an estimated $298K sold.

Invesco first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $298K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Invesco reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Invesco sold 4,960 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $298K.
Invesco first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Invesco's Pandion Therapeutics Inc. Common Stock position peaked at $298K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.